Stress pathway identified as potential therapeutic target to prevent vision loss
February 8, 2012 in Neuroscience
A new study identifies specific cell-stress signaling pathways that link injury of the optic nerve with irreversible vision loss. The research, published by Cell Press in the February 9 issue of the journal Neuron, may lead to new strategies that will help to protect vulnerable neurons in the retina after optic nerve damage and diseases.
Retinal ganglion cells (RGCs) send visual information from the retina to the brain through long processes called axons. The axons of the RGCs are bundled together to form the optic nerve. "RGCs are highly vulnerable when then optic nerve is damaged," explains senior study author, Dr. Zhigang He, from Children's Hospital and Harvard Medical School. "For example, optic nerve injury and subsequent loss of RGCs occur often in the setting of head injury and other types of retinal pathology, such as glaucoma."
Previous work has linked a cell-death pathway, called apoptosis, with trauma-related RGC death. However, targeting apoptosis is not seen as an efficient therapeutic strategy because apoptosis is likely to be one of the last steps in the disease process. In the current study, Dr. He and colleagues used an optic nerve crush model to investigate signals that are farther upstream of RGC death. The researchers discovered that optic nerve crush induced activation of distinct pathways of the unfolded protein response (UPR). The UPR is a cellular stress response that can be protective in some cell types.
The researchers went on to show that diverse UPR pathways are activated by axon injury and that the way these pathways function in neurons may be quite different from other cell types. Specifically, they suggest that axonal damage results in pro-cell-death UPR activation, which might contribute to irreversible cell death associated with optic nerve injury and glaucoma.
"Importantly, such differential activations of UPR pathways and their distinct effects on neuronal cell death are also observed in RGCs with other types of axonal insults, such as intraocular pressure elevation," concludes Dr. He. "This suggests a new protective strategy for optic nerve injury and diseases. In addition, as axonal damage is common in different neurodegenerative diseases, it would be interesting to see whether what we learned from optic nerve injury models is applicable to other types of neurodegeneration."
More information: Hu et al.: Differential Effects of Unfolded Protein Response Pathways on Axon Injury-Induced Death of Retinal Ganglion Cells. Neuron, DOI:10.1016/j.neuron.2011.11.026
Abstract
Loss of retinal ganglion cells (RGCs) accounts for visual function deficits after optic nerve injury, but how axonal insults lead to neuronal death remains elusive. By using an optic nerve crush model that results in the death of the majority of RGCs, we demonstrate that axotomy induces differential activation of distinct pathways of the unfolded protein response in axotomized RGCs. Optic nerve injury provokes a sustained CCAAT/enhancer binding homologous protein (CHOP) upregulation, and deletion of CHOP promotes RGC survival. In contrast, IRE/XBP-1 is only transiently activated, and forced XBP-1 activation dramatically protects RGCs from axon injury-induced death. Importantly, such differential activations of CHOP and XBP-1 and their distinct effects on neuronal cell death are also observed in RGCs with other types of axonal insults, such as vincristine treatment and intraocular pressure elevation, suggesting a new protective strategy for neurodegeneration associated with axonal damage.
Journal reference:
Neuron
Provided by
Cell Press
-
Better treatment sought for blinding traumatic optic nerve damage
Apr 06, 2011 |
not rated yet |
0
-
Cell's split personality is a major discovery into neurological diseases
May 07, 2009 |
not rated yet |
0
-
Brain holds early signs of glaucoma
Mar 01, 2010 |
not rated yet |
0
-
Coaxing injured nerve fibers to regenerate by disabling 'brakes' in the system
Dec 09, 2009 |
not rated yet |
0
-
Extensive regeneration in nerve connecting eye to brain achieved
Dec 06, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Neuroscience
May 18, 2013 |
5 / 5 (1) |
0
|
Temporal processing in the olfactory system
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
Neuroscience
May 17, 2013 |
4 / 5 (1) |
0
|
Melon focus headband turns to Kickstarter for rollout plans
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Neuroscience
May 17, 2013 |
3.7 / 5 (3) |
0
|
Deep brain stimulation: A fix when the drugs don't work
Neurological disorders can have a devastating impact on the lives of sufferers and their families.
Neuroscience
May 17, 2013 |
5 / 5 (1) |
0
|
Brain makes call on which ear is used for cell phone
If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit.
Neuroscience
May 16, 2013 |
2 / 5 (2) |
0
|
Blame your parents for bunion woes
A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...
Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.
Treatment of sleep apnea improves glucose levels in prediabetes
Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in ...
Commonly used catheters double risk of blood clots in ICU and cancer patients
Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.
Molecular marker from pancreatic 'juices' helps identify pancreatic cancer
Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis—two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic ...
Genetic diversity within tumors predicts outcome in head and neck cancer
A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...